CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines.
We commercialise and distribute a portfolio of speciality brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships.
Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.
We aim to have a positive impact on society through our pioneering focus on our Environment, Social and Governance (ESG) goals.
CNX participates in the Impetus Private Equity Triathlon
On Saturday 16th September, a day blessed by the last of the beautiful summer weather, a pioneering team of employees – none of whom have ever previously competed in any kind of sporting event – bravely represented CNX at the Impetus Private Equity Triathlon!
By participating in the triathlon CNX raised money for Impetus, an organisation what works to transform the lives of young people from disadvantaged backgrounds by making sure they get the right support to succeed in school, in work and in life.